KHPG(SZ:002773) Xin Lang Zheng Quan·2025-11-10 05:32Core Viewpoint - Kanghong Pharmaceutical's stock has shown significant volatility, with a year-to-date increase of 67.32%, but recent declines in the short term indicate potential market concerns [1][2]. Financial Performance - For the period from January to September 2025, Kanghong Pharmaceutical reported a revenue of 3.624 billion yuan, reflecting a year-on-year growth of 6.23%. The net profit attributable to shareholders was 1.033 billion yuan, with a growth of 6.08% compared to the previous year [2]. - The company has distributed a total of 2.038 billion yuan in dividends since its A-share listing, with 1.040 billion yuan distributed over the last three years [3]. Stock Market Activity - As of November 10, 2023, Kanghong Pharmaceutical's stock price was 31.79 yuan per share, with a market capitalization of 29.289 billion yuan. The stock experienced a trading volume of 147 million yuan and a turnover rate of 0.68% [1]. - The stock has seen a net outflow of 4.0184 million yuan from major funds, with significant buying and selling activity from large orders [1]. Shareholder Structure - As of October 20, 2023, the number of shareholders increased to 24,900, a rise of 3.53%. The average number of circulating shares per shareholder decreased by 3.41% to 27,592 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 28.007 million shares, an increase of 730,000 shares from the previous period [3].